Merck Serono plans building pharmaceutical manufacturing facility in China

Merck Serono to build pharmaceutical manufacturing facility in China

11:41 AM, 27th August 2014
Merck Serono plans building pharmaceutical manufacturing facility in China

NANTONG, CHINA: Merck Serono, the biopharmaceutical division of Merck, held the groundbreaking ceremony for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be the Group’s second-largest pharmaceutical manufacturing facility worldwide, will focus on the bulk production and packaging of Glucophage, Concor and Euthyrox, Merck Serono’s leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively. These medicines are referenced in China’s essential drug list, making Merck Serono the first and only multinational company in China to dedicate a large scale green-field investment to the production of drugs on the list, comprising medicines that address public healthcare needs and must be available at all times.

 

“We have steadfastly aligned our focus and strategy with the Chinese government’s efforts to increase patient access to quality care throughout the country. Today, we are focused on localizing production to better cater to the demands of Chinese doctors and patients. At the same time, we are localizing research and development to further build a differentiated portfolio of medicines in China, aimed at serving patient needs for general as well as specialized care. We are also creating alliances and partnerships with local partners in every part of our operations,” said Belen Garijo, President and Chief Executive Officer, Merck Serono.
© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


DSM expands omega-3 production facility in Nova Scotia, Canada

PARSIPPANY, US: DSM Nutritional Products will invest at least $30 million in new capital to upgrade and expand its facilities in Mulgrave, Nova Scotia ...

Read more
Umicore acquires assets of CP Chemicals in Ohio, US

OHIO, US: Umicore announced the acquisition of the business and assets of CP Chemicals in Wickliffe, Ohio, US. CP Chemicals is a refiner and recycler ...

Read more
CB&I bags grassroots petrochemicals complex contract in China

THE WOODLANDS, US: CB&I has been awarded a contract by Shenhua Ningxia Coal Industry Group Co Ltd for the license and engineering design of a gras ...

Read more
Newly developed glucose metre changes colour with glucose levels fluctuations

CHAMPAIGN, US: University of Illinois engineers are bringing a touch of colour to glucose monitoring. The researchers developed a new continuous gluco ...

Read more
BASF opens formulation, packaging plant in China

RUDONG, CHINA: BASF Crop Protection opened its first formulation and packaging plant in Yangkou Chemical Industrial Park, Rudong, Jiangsu Province, Ch ...

Read more
China imposes anti-dumping duties on TBHQ imports from India

BEIJING, CHINA: China imposed an anti-dumping duty on Indian companies stating that they were found to have dumped tertiary-butylhydroquinone (TBHQ) p ...

Read more